XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation Plans
6 Months Ended
Jun. 30, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation Plans
NOTE 14 – STOCK-BASED COMPENSATION PLANS
The Company grants stock options and stock equivalent units (“SEUs”) from time to time as a long-term performance incentive. In certain cases the grants are subject to performance conditions such as the Company’s stock price. Where performance conditions apply the Monte Carlo simulation model is used to determine the fair values. Otherwise the Black-Scholes model is used to determine the fair values.
Stock option plans
The following table summarizes the transactions of the Company’s stock option plans for the six months ended June 30, 2020:
 
    
Number of

Options
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Grant-Date

Fair Value
 
Outstanding at December 31, 2019
     504,459      $ 33.05      $ 41.35  
Granted - at discount
     63,950      $ 1.11      $ 76.80  
              - at market value
     10,419      $ 95.70      $ 18.69  
Exercised
     (81,860    $ 9.73      $ 52.31  
Forfeited
     (13,161    $ 22.43      $ 45.20  
  
 
 
       
Outstanding at June 30, 2020
     483,807      $ 34.41      $ 43.59  
  
 
 
       
At June 30, 2020, there were 43,638 stock options that were exercisable, of which 8,779 had performance conditions attached.
The stock option compensation cost for the first six months of 2020 was $2.8 million (first six months of 2019 – $3.2 million). The total intrinsic value of options exercised in the first six months of 2020 was $4.6 million (first six months of 2019 – $2.7 million).
The total compensation cost related to
non-vested
stock options not yet recognized at June 30, 2020 was $10.2 million and this cost is expected to be recognized over the weighted-average period of 1.93 years.
Stock equivalent units
The following table summarizes the transactions of the Company’s SEUs for the six months ended June 30, 2020:
 
    
Number
of SEUs
    
Weighted
Average
Exercise
Price
    
Weighted

Average
Grant-Date

Fair Value
 
Outstanding at December 31, 2019
     390,816      $ 3.69      $ 59.91  
Granted - at discount
     108,607      $ 0.00      $ 76.86  
              - at market value
     3,634      $ 95.70      $ 18.69  
Exercised
     (88,557    $ 0.86      $ 60.55  
Forfeited
     (17,036    $ 0.86      $ 65.38  
  
 
 
       
Outstanding at June 30, 2020
     397,464      $ 4.27      $ 63.79  
  
 
 
       
At June 30, 2020 there were 57,696 SEUs that are exercisable, of which 51,164 had performance conditions attached.
The charges for SEUs are spread over the life of the award subject to a revaluation to fair value each quarter. The revaluation may result in a charge or a credit to the income statement in the quarter dependent upon our share price and other performance criteria.
The SEU compensation for the first six months of 2020 was a $3.0 million credit (first six months of 2019 – $11.8 million charge). The total intrinsic value of SEUs exercised in the first six months of 2020 was $6.1 million (first six months of 2019 – $7.1 million).
The weighted-average remaining vesting period of
non-vested
SEUs is 2.20 years.